nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluorouracil—Nucleic Acid Synthesis Inhibitors—Capecitabine—colon cancer	0.361	1	CiPCiCtD
Fluorouracil—TYMS—colon cancer	0.124	1	CbGaD
Fluorouracil—breast cancer—colon cancer	0.0936	0.375	CtDrD
Fluorouracil—stomach cancer—colon cancer	0.0807	0.323	CtDrD
Fluorouracil—DPYD—Capecitabine—colon cancer	0.0759	0.369	CbGbCtD
Fluorouracil—pancreatic cancer—colon cancer	0.0752	0.302	CtDrD
Fluorouracil—TYMP—Capecitabine—colon cancer	0.0504	0.245	CbGbCtD
Fluorouracil—TYMS—Capecitabine—colon cancer	0.0268	0.13	CbGbCtD
Fluorouracil—MTHFR—Methotrexate—colon cancer	0.0103	0.0501	CbGbCtD
Fluorouracil—TYMS—Methotrexate—colon cancer	0.00877	0.0427	CbGbCtD
Fluorouracil—ABCC3—Vincristine—colon cancer	0.00751	0.0365	CbGbCtD
Fluorouracil—ABCC3—Methotrexate—colon cancer	0.00455	0.0221	CbGbCtD
Fluorouracil—SLC22A7—Methotrexate—colon cancer	0.00356	0.0173	CbGbCtD
Fluorouracil—ABCG2—Irinotecan—colon cancer	0.00353	0.0172	CbGbCtD
Fluorouracil—ABCC4—Methotrexate—colon cancer	0.00348	0.0169	CbGbCtD
Fluorouracil—ABCG2—Vincristine—colon cancer	0.00309	0.015	CbGbCtD
Fluorouracil—ALB—Irinotecan—colon cancer	0.00243	0.0118	CbGbCtD
Fluorouracil—CYP2C9—Capecitabine—colon cancer	0.00212	0.0103	CbGbCtD
Fluorouracil—ABCG2—Methotrexate—colon cancer	0.00187	0.00909	CbGbCtD
Fluorouracil—ALB—Methotrexate—colon cancer	0.00129	0.00627	CbGbCtD
Fluorouracil—UPP2—renal system—colon cancer	0.00101	0.0599	CbGeAlD
Fluorouracil—UPP2—liver—colon cancer	0.000619	0.0366	CbGeAlD
Fluorouracil—TYMP—endothelium—colon cancer	0.000596	0.0352	CbGeAlD
Fluorouracil—TYMP—blood vessel—colon cancer	0.00055	0.0325	CbGeAlD
Fluorouracil—MTHFR—blood vessel—colon cancer	0.000517	0.0305	CbGeAlD
Fluorouracil—UMPS—digestive system—colon cancer	0.000472	0.0279	CbGeAlD
Fluorouracil—UMPS—bone marrow—colon cancer	0.000435	0.0257	CbGeAlD
Fluorouracil—UPP1—digestive system—colon cancer	0.000433	0.0255	CbGeAlD
Fluorouracil—UMPS—vagina—colon cancer	0.000417	0.0246	CbGeAlD
Fluorouracil—UPP1—bone marrow—colon cancer	0.000399	0.0235	CbGeAlD
Fluorouracil—UPP1—vagina—colon cancer	0.000382	0.0226	CbGeAlD
Fluorouracil—ABCC3—gall bladder—colon cancer	0.000364	0.0215	CbGeAlD
Fluorouracil—UMPS—liver—colon cancer	0.000351	0.0208	CbGeAlD
Fluorouracil—DPYD—bone marrow—colon cancer	0.000324	0.0191	CbGeAlD
Fluorouracil—UPP1—liver—colon cancer	0.000322	0.019	CbGeAlD
Fluorouracil—ALB—gall bladder—colon cancer	0.00031	0.0183	CbGeAlD
Fluorouracil—TYMS—Vinorelbine—Vincristine—colon cancer	0.000284	0.593	CbGdCrCtD
Fluorouracil—PPAT—bone marrow—colon cancer	0.00028	0.0165	CbGeAlD
Fluorouracil—UMPS—lymph node—colon cancer	0.000269	0.0159	CbGeAlD
Fluorouracil—PPAT—vagina—colon cancer	0.000268	0.0159	CbGeAlD
Fluorouracil—DPYD—liver—colon cancer	0.000262	0.0155	CbGeAlD
Fluorouracil—TYMP—smooth muscle tissue—colon cancer	0.000258	0.0152	CbGeAlD
Fluorouracil—SLC22A7—renal system—colon cancer	0.000247	0.0146	CbGeAlD
Fluorouracil—UPP1—lymph node—colon cancer	0.000247	0.0146	CbGeAlD
Fluorouracil—PPAT—liver—colon cancer	0.000226	0.0134	CbGeAlD
Fluorouracil—TYMS—smooth muscle tissue—colon cancer	0.000221	0.0131	CbGeAlD
Fluorouracil—TYMP—lymphoid tissue—colon cancer	0.000206	0.0122	CbGeAlD
Fluorouracil—TYMP—digestive system—colon cancer	0.000204	0.012	CbGeAlD
Fluorouracil—SLC22A7—digestive system—colon cancer	0.000203	0.012	CbGeAlD
Fluorouracil—DPYD—lymph node—colon cancer	0.000201	0.0118	CbGeAlD
Fluorouracil—TYMS—Vinblastine—Vincristine—colon cancer	0.000195	0.407	CbGdCrCtD
Fluorouracil—MTHFR—lymphoid tissue—colon cancer	0.000194	0.0114	CbGeAlD
Fluorouracil—MTHFR—digestive system—colon cancer	0.000191	0.0113	CbGeAlD
Fluorouracil—SLC29A1—renal system—colon cancer	0.000191	0.0113	CbGeAlD
Fluorouracil—TYMP—bone marrow—colon cancer	0.000188	0.0111	CbGeAlD
Fluorouracil—TYMP—vagina—colon cancer	0.00018	0.0106	CbGeAlD
Fluorouracil—TYMS—lymphoid tissue—colon cancer	0.000177	0.0104	CbGeAlD
Fluorouracil—TYMS—digestive system—colon cancer	0.000175	0.0103	CbGeAlD
Fluorouracil—ABCC3—renal system—colon cancer	0.000175	0.0103	CbGeAlD
Fluorouracil—PPAT—lymph node—colon cancer	0.000174	0.0103	CbGeAlD
Fluorouracil—Speech disorder—Irinotecan—colon cancer	0.000171	0.00726	CcSEcCtD
Fluorouracil—Pericarditis—Methotrexate—colon cancer	0.000169	0.00719	CcSEcCtD
Fluorouracil—Extravasation—Irinotecan—colon cancer	0.000169	0.00715	CcSEcCtD
Fluorouracil—Skin hyperpigmentation—Capecitabine—colon cancer	0.000165	0.00702	CcSEcCtD
Fluorouracil—Febrile neutropenia—Capecitabine—colon cancer	0.000164	0.00694	CcSEcCtD
Fluorouracil—TYMS—bone marrow—colon cancer	0.000161	0.0095	CbGeAlD
Fluorouracil—Lacrimation increased—Irinotecan—colon cancer	0.00016	0.00677	CcSEcCtD
Fluorouracil—SLC29A1—lymphoid tissue—colon cancer	0.000159	0.00936	CbGeAlD
Fluorouracil—ABCC5—bone marrow—colon cancer	0.000157	0.00928	CbGeAlD
Fluorouracil—SLC29A1—digestive system—colon cancer	0.000157	0.00925	CbGeAlD
Fluorouracil—Dysarthria—Irinotecan—colon cancer	0.000155	0.0066	CcSEcCtD
Fluorouracil—Ulcer—Irinotecan—colon cancer	0.000155	0.0066	CcSEcCtD
Fluorouracil—TYMS—vagina—colon cancer	0.000154	0.00911	CbGeAlD
Fluorouracil—Encephalopathy—Capecitabine—colon cancer	0.000153	0.00651	CcSEcCtD
Fluorouracil—Nail disorder—Capecitabine—colon cancer	0.000152	0.00644	CcSEcCtD
Fluorouracil—TYMP—liver—colon cancer	0.000152	0.00895	CbGeAlD
Fluorouracil—SLC22A7—liver—colon cancer	0.000151	0.00893	CbGeAlD
Fluorouracil—ABCC5—vagina—colon cancer	0.000151	0.00889	CbGeAlD
Fluorouracil—SLC29A1—bone marrow—colon cancer	0.000144	0.00852	CbGeAlD
Fluorouracil—ABCC4—renal system—colon cancer	0.000144	0.00851	CbGeAlD
Fluorouracil—ABCC3—digestive system—colon cancer	0.000143	0.00846	CbGeAlD
Fluorouracil—Sudden death—Methotrexate—colon cancer	0.000143	0.00608	CcSEcCtD
Fluorouracil—MTHFR—liver—colon cancer	0.000143	0.00842	CbGeAlD
Fluorouracil—SLC29A1—vagina—colon cancer	0.000138	0.00817	CbGeAlD
Fluorouracil—Coma—Vincristine—colon cancer	0.000138	0.00586	CcSEcCtD
Fluorouracil—Blister—Capecitabine—colon cancer	0.000137	0.00579	CcSEcCtD
Fluorouracil—CYP2A6—vagina—colon cancer	0.000135	0.00797	CbGeAlD
Fluorouracil—TYMS—liver—colon cancer	0.00013	0.00768	CbGeAlD
Fluorouracil—Sepsis—Irinotecan—colon cancer	0.000128	0.00542	CcSEcCtD
Fluorouracil—ABCC5—liver—colon cancer	0.000127	0.0075	CbGeAlD
Fluorouracil—Thrombophlebitis—Irinotecan—colon cancer	0.000123	0.00523	CcSEcCtD
Fluorouracil—Skin hyperpigmentation—Methotrexate—colon cancer	0.000123	0.00523	CcSEcCtD
Fluorouracil—Myocardial ischaemia—Capecitabine—colon cancer	0.000122	0.0052	CcSEcCtD
Fluorouracil—Tingling sensation—Capecitabine—colon cancer	0.000122	0.0052	CcSEcCtD
Fluorouracil—Febrile neutropenia—Methotrexate—colon cancer	0.000122	0.00517	CcSEcCtD
Fluorouracil—ABCC4—digestive system—colon cancer	0.000118	0.00698	CbGeAlD
Fluorouracil—SLC29A1—liver—colon cancer	0.000117	0.00689	CbGeAlD
Fluorouracil—TYMP—lymph node—colon cancer	0.000116	0.00686	CbGeAlD
Fluorouracil—Eye irritation—Capecitabine—colon cancer	0.000115	0.00489	CcSEcCtD
Fluorouracil—Encephalopathy—Methotrexate—colon cancer	0.000114	0.00484	CcSEcCtD
Fluorouracil—CYP2A6—liver—colon cancer	0.000114	0.00673	CbGeAlD
Fluorouracil—Nail disorder—Methotrexate—colon cancer	0.000113	0.00479	CcSEcCtD
Fluorouracil—MTHFR—lymph node—colon cancer	0.000109	0.00645	CbGeAlD
Fluorouracil—ABCC4—bone marrow—colon cancer	0.000109	0.00643	CbGeAlD
Fluorouracil—Cellulitis—Capecitabine—colon cancer	0.000108	0.00459	CcSEcCtD
Fluorouracil—Herpes simplex—Capecitabine—colon cancer	0.000107	0.00453	CcSEcCtD
Fluorouracil—Lacrimation increased—Capecitabine—colon cancer	0.000107	0.00453	CcSEcCtD
Fluorouracil—Gastrointestinal haemorrhage—Irinotecan—colon cancer	0.000107	0.00453	CcSEcCtD
Fluorouracil—Osteoarthritis—Irinotecan—colon cancer	0.000107	0.00453	CcSEcCtD
Fluorouracil—ABCC3—liver—colon cancer	0.000107	0.0063	CbGeAlD
Fluorouracil—CYP2C8—renal system—colon cancer	0.000105	0.00618	CbGeAlD
Fluorouracil—Cardiac arrest—Vincristine—colon cancer	0.000104	0.00442	CcSEcCtD
Fluorouracil—Ulcer—Capecitabine—colon cancer	0.000104	0.00442	CcSEcCtD
Fluorouracil—Dysarthria—Capecitabine—colon cancer	0.000104	0.00442	CcSEcCtD
Fluorouracil—Ataxia—Vincristine—colon cancer	0.000103	0.00437	CcSEcCtD
Fluorouracil—Cardiac arrest—Irinotecan—colon cancer	0.000102	0.00431	CcSEcCtD
Fluorouracil—Inflammation—Capecitabine—colon cancer	0.000101	0.00431	CcSEcCtD
Fluorouracil—TYMS—lymph node—colon cancer	9.97e-05	0.00589	CbGeAlD
Fluorouracil—CYP1A2—renal system—colon cancer	9.79e-05	0.00578	CbGeAlD
Fluorouracil—ABCC5—lymph node—colon cancer	9.74e-05	0.00575	CbGeAlD
Fluorouracil—Muscular weakness—Vincristine—colon cancer	9.67e-05	0.0041	CcSEcCtD
Fluorouracil—Necrosis—Methotrexate—colon cancer	9.34e-05	0.00396	CcSEcCtD
Fluorouracil—ALB—liver—colon cancer	9.1e-05	0.00537	CbGeAlD
Fluorouracil—Pancytopenia—Vincristine—colon cancer	9e-05	0.00382	CcSEcCtD
Fluorouracil—Oesophagitis—Capecitabine—colon cancer	8.99e-05	0.00382	CcSEcCtD
Fluorouracil—Angina pectoris—Irinotecan—colon cancer	8.99e-05	0.00381	CcSEcCtD
Fluorouracil—SLC29A1—lymph node—colon cancer	8.94e-05	0.00528	CbGeAlD
Fluorouracil—ABCC4—liver—colon cancer	8.81e-05	0.0052	CbGeAlD
Fluorouracil—Photosensitivity reaction—Vincristine—colon cancer	8.65e-05	0.00367	CcSEcCtD
Fluorouracil—Upper respiratory tract infection—Irinotecan—colon cancer	8.58e-05	0.00364	CcSEcCtD
Fluorouracil—Sepsis—Capecitabine—colon cancer	8.54e-05	0.00362	CcSEcCtD
Fluorouracil—Speech disorder—Methotrexate—colon cancer	8.52e-05	0.00361	CcSEcCtD
Fluorouracil—Pneumonia—Vincristine—colon cancer	8.5e-05	0.00361	CcSEcCtD
Fluorouracil—Extravasation—Methotrexate—colon cancer	8.4e-05	0.00356	CcSEcCtD
Fluorouracil—Acute coronary syndrome—Vincristine—colon cancer	8.33e-05	0.00353	CcSEcCtD
Fluorouracil—Myocardial infarction—Vincristine—colon cancer	8.28e-05	0.00351	CcSEcCtD
Fluorouracil—Neuropathy peripheral—Vincristine—colon cancer	8.28e-05	0.00351	CcSEcCtD
Fluorouracil—Pneumonia—Irinotecan—colon cancer	8.27e-05	0.00351	CcSEcCtD
Fluorouracil—Thrombophlebitis—Capecitabine—colon cancer	8.25e-05	0.0035	CcSEcCtD
Fluorouracil—Stomatitis—Vincristine—colon cancer	8.23e-05	0.00349	CcSEcCtD
Fluorouracil—ABCC3—lymph node—colon cancer	8.18e-05	0.00483	CbGeAlD
Fluorouracil—Photosensitivity—Capecitabine—colon cancer	8.14e-05	0.00345	CcSEcCtD
Fluorouracil—Acute coronary syndrome—Irinotecan—colon cancer	8.11e-05	0.00344	CcSEcCtD
Fluorouracil—Swelling—Capecitabine—colon cancer	8.1e-05	0.00344	CcSEcCtD
Fluorouracil—Myocardial infarction—Irinotecan—colon cancer	8.06e-05	0.00342	CcSEcCtD
Fluorouracil—CYP1A2—digestive system—colon cancer	8.03e-05	0.00474	CbGeAlD
Fluorouracil—Stomatitis—Irinotecan—colon cancer	8.02e-05	0.0034	CcSEcCtD
Fluorouracil—Herpes simplex—Methotrexate—colon cancer	7.95e-05	0.00337	CcSEcCtD
Fluorouracil—Ulcer—Methotrexate—colon cancer	7.75e-05	0.00329	CcSEcCtD
Fluorouracil—Dysarthria—Methotrexate—colon cancer	7.75e-05	0.00329	CcSEcCtD
Fluorouracil—ABCG2—bone marrow—colon cancer	7.69e-05	0.00454	CbGeAlD
Fluorouracil—CYP2C9—digestive system—colon cancer	7.62e-05	0.0045	CbGeAlD
Fluorouracil—Amnesia—Capecitabine—colon cancer	7.6e-05	0.00323	CcSEcCtD
Fluorouracil—CYP2C8—vagina—colon cancer	7.58e-05	0.00448	CbGeAlD
Fluorouracil—Inflammation—Methotrexate—colon cancer	7.55e-05	0.00321	CcSEcCtD
Fluorouracil—Hypoaesthesia—Vincristine—colon cancer	7.55e-05	0.0032	CcSEcCtD
Fluorouracil—Dermatitis bullous—Capecitabine—colon cancer	7.48e-05	0.00317	CcSEcCtD
Fluorouracil—Haemoglobin—Irinotecan—colon cancer	7.42e-05	0.00315	CcSEcCtD
Fluorouracil—Rhinitis—Irinotecan—colon cancer	7.4e-05	0.00314	CcSEcCtD
Fluorouracil—Haemorrhage—Irinotecan—colon cancer	7.39e-05	0.00313	CcSEcCtD
Fluorouracil—ABCG2—vagina—colon cancer	7.37e-05	0.00435	CbGeAlD
Fluorouracil—Cardiac failure—Capecitabine—colon cancer	7.32e-05	0.00311	CcSEcCtD
Fluorouracil—Lethargy—Capecitabine—colon cancer	7.29e-05	0.00309	CcSEcCtD
Fluorouracil—Osteoarthritis—Capecitabine—colon cancer	7.15e-05	0.00303	CcSEcCtD
Fluorouracil—Gastrointestinal haemorrhage—Capecitabine—colon cancer	7.15e-05	0.00303	CcSEcCtD
Fluorouracil—ALB—lymph node—colon cancer	6.98e-05	0.00412	CbGeAlD
Fluorouracil—Irritability—Capecitabine—colon cancer	6.82e-05	0.00289	CcSEcCtD
Fluorouracil—Cardiac arrest—Capecitabine—colon cancer	6.79e-05	0.00288	CcSEcCtD
Fluorouracil—ABCC4—lymph node—colon cancer	6.75e-05	0.00399	CbGeAlD
Fluorouracil—Ataxia—Capecitabine—colon cancer	6.72e-05	0.00285	CcSEcCtD
Fluorouracil—Alopecia—Vincristine—colon cancer	6.7e-05	0.00284	CcSEcCtD
Fluorouracil—Coma—Methotrexate—colon cancer	6.7e-05	0.00284	CcSEcCtD
Fluorouracil—Arrhythmia—Irinotecan—colon cancer	6.6e-05	0.0028	CcSEcCtD
Fluorouracil—Dry skin—Capecitabine—colon cancer	6.55e-05	0.00278	CcSEcCtD
Fluorouracil—Alopecia—Irinotecan—colon cancer	6.53e-05	0.00277	CcSEcCtD
Fluorouracil—CYP2C8—liver—colon cancer	6.39e-05	0.00378	CbGeAlD
Fluorouracil—Nasopharyngitis—Capecitabine—colon cancer	6.39e-05	0.00271	CcSEcCtD
Fluorouracil—Sepsis—Methotrexate—colon cancer	6.36e-05	0.0027	CcSEcCtD
Fluorouracil—Muscular weakness—Capecitabine—colon cancer	6.3e-05	0.00267	CcSEcCtD
Fluorouracil—ABCG2—liver—colon cancer	6.22e-05	0.00367	CbGeAlD
Fluorouracil—Dysphagia—Capecitabine—colon cancer	6.18e-05	0.00262	CcSEcCtD
Fluorouracil—Thrombophlebitis—Methotrexate—colon cancer	6.14e-05	0.00261	CcSEcCtD
Fluorouracil—Anaemia—Vincristine—colon cancer	6.1e-05	0.00259	CcSEcCtD
Fluorouracil—Photosensitivity—Methotrexate—colon cancer	6.06e-05	0.00257	CcSEcCtD
Fluorouracil—Angina pectoris—Capecitabine—colon cancer	6.02e-05	0.00255	CcSEcCtD
Fluorouracil—CYP1A2—liver—colon cancer	5.98e-05	0.00353	CbGeAlD
Fluorouracil—Anaemia—Irinotecan—colon cancer	5.94e-05	0.00252	CcSEcCtD
Fluorouracil—Leukopenia—Vincristine—colon cancer	5.91e-05	0.00251	CcSEcCtD
Fluorouracil—Pancytopenia—Capecitabine—colon cancer	5.86e-05	0.00249	CcSEcCtD
Fluorouracil—Leukopenia—Irinotecan—colon cancer	5.75e-05	0.00244	CcSEcCtD
Fluorouracil—Upper respiratory tract infection—Capecitabine—colon cancer	5.74e-05	0.00244	CcSEcCtD
Fluorouracil—Convulsion—Vincristine—colon cancer	5.72e-05	0.00243	CcSEcCtD
Fluorouracil—CYP2C9—liver—colon cancer	5.68e-05	0.00335	CbGeAlD
Fluorouracil—Photosensitivity reaction—Capecitabine—colon cancer	5.64e-05	0.00239	CcSEcCtD
Fluorouracil—Myalgia—Vincristine—colon cancer	5.62e-05	0.00238	CcSEcCtD
Fluorouracil—Pneumonia—Capecitabine—colon cancer	5.54e-05	0.00235	CcSEcCtD
Fluorouracil—Infestation NOS—Capecitabine—colon cancer	5.51e-05	0.00234	CcSEcCtD
Fluorouracil—Infestation—Capecitabine—colon cancer	5.51e-05	0.00234	CcSEcCtD
Fluorouracil—Acute coronary syndrome—Capecitabine—colon cancer	5.43e-05	0.0023	CcSEcCtD
Fluorouracil—Lethargy—Methotrexate—colon cancer	5.43e-05	0.0023	CcSEcCtD
Fluorouracil—Discomfort—Irinotecan—colon cancer	5.41e-05	0.00229	CcSEcCtD
Fluorouracil—Myocardial infarction—Capecitabine—colon cancer	5.4e-05	0.00229	CcSEcCtD
Fluorouracil—Neuropathy peripheral—Capecitabine—colon cancer	5.4e-05	0.00229	CcSEcCtD
Fluorouracil—Anaphylactic shock—Vincristine—colon cancer	5.39e-05	0.00229	CcSEcCtD
Fluorouracil—Oedema—Vincristine—colon cancer	5.39e-05	0.00229	CcSEcCtD
Fluorouracil—Stomatitis—Capecitabine—colon cancer	5.37e-05	0.00228	CcSEcCtD
Fluorouracil—Infection—Vincristine—colon cancer	5.35e-05	0.00227	CcSEcCtD
Fluorouracil—Urinary tract infection—Capecitabine—colon cancer	5.35e-05	0.00227	CcSEcCtD
Fluorouracil—Conjunctivitis—Capecitabine—colon cancer	5.35e-05	0.00227	CcSEcCtD
Fluorouracil—Osteoarthritis—Methotrexate—colon cancer	5.32e-05	0.00226	CcSEcCtD
Fluorouracil—Confusional state—Irinotecan—colon cancer	5.29e-05	0.00224	CcSEcCtD
Fluorouracil—Nervous system disorder—Vincristine—colon cancer	5.28e-05	0.00224	CcSEcCtD
Fluorouracil—Thrombocytopenia—Vincristine—colon cancer	5.28e-05	0.00224	CcSEcCtD
Fluorouracil—Anaphylactic shock—Irinotecan—colon cancer	5.25e-05	0.00223	CcSEcCtD
Fluorouracil—Oedema—Irinotecan—colon cancer	5.25e-05	0.00223	CcSEcCtD
Fluorouracil—Infection—Irinotecan—colon cancer	5.21e-05	0.00221	CcSEcCtD
Fluorouracil—Epistaxis—Capecitabine—colon cancer	5.19e-05	0.0022	CcSEcCtD
Fluorouracil—Nervous system disorder—Irinotecan—colon cancer	5.15e-05	0.00218	CcSEcCtD
Fluorouracil—Agranulocytosis—Capecitabine—colon cancer	5.14e-05	0.00218	CcSEcCtD
Fluorouracil—Thrombocytopenia—Irinotecan—colon cancer	5.14e-05	0.00218	CcSEcCtD
Fluorouracil—Anorexia—Vincristine—colon cancer	5.14e-05	0.00218	CcSEcCtD
Fluorouracil—Irritability—Methotrexate—colon cancer	5.08e-05	0.00215	CcSEcCtD
Fluorouracil—Hypotension—Vincristine—colon cancer	5.03e-05	0.00214	CcSEcCtD
Fluorouracil—Anorexia—Irinotecan—colon cancer	5e-05	0.00212	CcSEcCtD
Fluorouracil—Ataxia—Methotrexate—colon cancer	5e-05	0.00212	CcSEcCtD
Fluorouracil—Haemoglobin—Capecitabine—colon cancer	4.97e-05	0.00211	CcSEcCtD
Fluorouracil—Rhinitis—Capecitabine—colon cancer	4.96e-05	0.0021	CcSEcCtD
Fluorouracil—Haemorrhage—Capecitabine—colon cancer	4.94e-05	0.0021	CcSEcCtD
Fluorouracil—Hypoaesthesia—Capecitabine—colon cancer	4.92e-05	0.00209	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Vincristine—colon cancer	4.91e-05	0.00208	CcSEcCtD
Fluorouracil—Pharyngitis—Capecitabine—colon cancer	4.91e-05	0.00208	CcSEcCtD
Fluorouracil—Hypotension—Irinotecan—colon cancer	4.9e-05	0.00208	CcSEcCtD
Fluorouracil—Insomnia—Vincristine—colon cancer	4.87e-05	0.00207	CcSEcCtD
Fluorouracil—Paraesthesia—Vincristine—colon cancer	4.84e-05	0.00205	CcSEcCtD
Fluorouracil—ABCG2—lymph node—colon cancer	4.77e-05	0.00281	CbGeAlD
Fluorouracil—Insomnia—Irinotecan—colon cancer	4.75e-05	0.00201	CcSEcCtD
Fluorouracil—Paraesthesia—Irinotecan—colon cancer	4.71e-05	0.002	CcSEcCtD
Fluorouracil—Decreased appetite—Vincristine—colon cancer	4.68e-05	0.00199	CcSEcCtD
Fluorouracil—Dyspnoea—Irinotecan—colon cancer	4.68e-05	0.00198	CcSEcCtD
Fluorouracil—Somnolence—Irinotecan—colon cancer	4.66e-05	0.00198	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Vincristine—colon cancer	4.65e-05	0.00197	CcSEcCtD
Fluorouracil—Dyspepsia—Irinotecan—colon cancer	4.62e-05	0.00196	CcSEcCtD
Fluorouracil—Pain—Vincristine—colon cancer	4.61e-05	0.00195	CcSEcCtD
Fluorouracil—Decreased appetite—Irinotecan—colon cancer	4.56e-05	0.00194	CcSEcCtD
Fluorouracil—Eosinophilia—Methotrexate—colon cancer	4.55e-05	0.00193	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Irinotecan—colon cancer	4.53e-05	0.00192	CcSEcCtD
Fluorouracil—Pain—Irinotecan—colon cancer	4.49e-05	0.0019	CcSEcCtD
Fluorouracil—Arrhythmia—Capecitabine—colon cancer	4.42e-05	0.00187	CcSEcCtD
Fluorouracil—Alopecia—Capecitabine—colon cancer	4.37e-05	0.00185	CcSEcCtD
Fluorouracil—Pancytopenia—Methotrexate—colon cancer	4.37e-05	0.00185	CcSEcCtD
Fluorouracil—Feeling abnormal—Irinotecan—colon cancer	4.32e-05	0.00183	CcSEcCtD
Fluorouracil—Erythema—Capecitabine—colon cancer	4.3e-05	0.00183	CcSEcCtD
Fluorouracil—Upper respiratory tract infection—Methotrexate—colon cancer	4.27e-05	0.00181	CcSEcCtD
Fluorouracil—Body temperature increased—Vincristine—colon cancer	4.26e-05	0.00181	CcSEcCtD
Fluorouracil—Photosensitivity reaction—Methotrexate—colon cancer	4.2e-05	0.00178	CcSEcCtD
Fluorouracil—Body temperature increased—Irinotecan—colon cancer	4.15e-05	0.00176	CcSEcCtD
Fluorouracil—Pneumonia—Methotrexate—colon cancer	4.12e-05	0.00175	CcSEcCtD
Fluorouracil—Infestation NOS—Methotrexate—colon cancer	4.1e-05	0.00174	CcSEcCtD
Fluorouracil—Infestation—Methotrexate—colon cancer	4.1e-05	0.00174	CcSEcCtD
Fluorouracil—Vision blurred—Capecitabine—colon cancer	4.06e-05	0.00172	CcSEcCtD
Fluorouracil—Stomatitis—Methotrexate—colon cancer	4e-05	0.0017	CcSEcCtD
Fluorouracil—Conjunctivitis—Methotrexate—colon cancer	3.98e-05	0.00169	CcSEcCtD
Fluorouracil—Anaemia—Capecitabine—colon cancer	3.98e-05	0.00169	CcSEcCtD
Fluorouracil—Hypersensitivity—Vincristine—colon cancer	3.97e-05	0.00168	CcSEcCtD
Fluorouracil—Epistaxis—Methotrexate—colon cancer	3.87e-05	0.00164	CcSEcCtD
Fluorouracil—Hypersensitivity—Irinotecan—colon cancer	3.87e-05	0.00164	CcSEcCtD
Fluorouracil—Leukopenia—Capecitabine—colon cancer	3.85e-05	0.00163	CcSEcCtD
Fluorouracil—Agranulocytosis—Methotrexate—colon cancer	3.83e-05	0.00162	CcSEcCtD
Fluorouracil—Haemoglobin—Methotrexate—colon cancer	3.7e-05	0.00157	CcSEcCtD
Fluorouracil—Diarrhoea—Vincristine—colon cancer	3.69e-05	0.00156	CcSEcCtD
Fluorouracil—Haemorrhage—Methotrexate—colon cancer	3.68e-05	0.00156	CcSEcCtD
Fluorouracil—Chest pain—Capecitabine—colon cancer	3.66e-05	0.00155	CcSEcCtD
Fluorouracil—Myalgia—Capecitabine—colon cancer	3.66e-05	0.00155	CcSEcCtD
Fluorouracil—Pharyngitis—Methotrexate—colon cancer	3.65e-05	0.00155	CcSEcCtD
Fluorouracil—Discomfort—Capecitabine—colon cancer	3.62e-05	0.00154	CcSEcCtD
Fluorouracil—Diarrhoea—Irinotecan—colon cancer	3.59e-05	0.00152	CcSEcCtD
Fluorouracil—Dizziness—Vincristine—colon cancer	3.56e-05	0.00151	CcSEcCtD
Fluorouracil—Confusional state—Capecitabine—colon cancer	3.54e-05	0.0015	CcSEcCtD
Fluorouracil—Oedema—Capecitabine—colon cancer	3.51e-05	0.00149	CcSEcCtD
Fluorouracil—Infection—Capecitabine—colon cancer	3.49e-05	0.00148	CcSEcCtD
Fluorouracil—Dizziness—Irinotecan—colon cancer	3.47e-05	0.00147	CcSEcCtD
Fluorouracil—Nervous system disorder—Capecitabine—colon cancer	3.44e-05	0.00146	CcSEcCtD
Fluorouracil—Thrombocytopenia—Capecitabine—colon cancer	3.44e-05	0.00146	CcSEcCtD
Fluorouracil—Tachycardia—Capecitabine—colon cancer	3.43e-05	0.00145	CcSEcCtD
Fluorouracil—Vomiting—Vincristine—colon cancer	3.43e-05	0.00145	CcSEcCtD
Fluorouracil—Rash—Vincristine—colon cancer	3.4e-05	0.00144	CcSEcCtD
Fluorouracil—Dermatitis—Vincristine—colon cancer	3.39e-05	0.00144	CcSEcCtD
Fluorouracil—Headache—Vincristine—colon cancer	3.38e-05	0.00143	CcSEcCtD
Fluorouracil—Anorexia—Capecitabine—colon cancer	3.35e-05	0.00142	CcSEcCtD
Fluorouracil—Vomiting—Irinotecan—colon cancer	3.34e-05	0.00142	CcSEcCtD
Fluorouracil—Rash—Irinotecan—colon cancer	3.31e-05	0.0014	CcSEcCtD
Fluorouracil—Dermatitis—Irinotecan—colon cancer	3.31e-05	0.0014	CcSEcCtD
Fluorouracil—Headache—Irinotecan—colon cancer	3.29e-05	0.00139	CcSEcCtD
Fluorouracil—Hypotension—Capecitabine—colon cancer	3.28e-05	0.00139	CcSEcCtD
Fluorouracil—Alopecia—Methotrexate—colon cancer	3.25e-05	0.00138	CcSEcCtD
Fluorouracil—Erythema—Methotrexate—colon cancer	3.2e-05	0.00136	CcSEcCtD
Fluorouracil—Nausea—Vincristine—colon cancer	3.2e-05	0.00136	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Capecitabine—colon cancer	3.2e-05	0.00136	CcSEcCtD
Fluorouracil—Insomnia—Capecitabine—colon cancer	3.18e-05	0.00135	CcSEcCtD
Fluorouracil—Paraesthesia—Capecitabine—colon cancer	3.15e-05	0.00134	CcSEcCtD
Fluorouracil—Dyspnoea—Capecitabine—colon cancer	3.13e-05	0.00133	CcSEcCtD
Fluorouracil—Nausea—Irinotecan—colon cancer	3.12e-05	0.00132	CcSEcCtD
Fluorouracil—Dyspepsia—Capecitabine—colon cancer	3.09e-05	0.00131	CcSEcCtD
Fluorouracil—Decreased appetite—Capecitabine—colon cancer	3.05e-05	0.0013	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Capecitabine—colon cancer	3.03e-05	0.00129	CcSEcCtD
Fluorouracil—Vision blurred—Methotrexate—colon cancer	3.02e-05	0.00128	CcSEcCtD
Fluorouracil—Pain—Capecitabine—colon cancer	3e-05	0.00127	CcSEcCtD
Fluorouracil—Anaemia—Methotrexate—colon cancer	2.96e-05	0.00126	CcSEcCtD
Fluorouracil—Feeling abnormal—Capecitabine—colon cancer	2.89e-05	0.00123	CcSEcCtD
Fluorouracil—Leukopenia—Methotrexate—colon cancer	2.87e-05	0.00122	CcSEcCtD
Fluorouracil—Urticaria—Capecitabine—colon cancer	2.79e-05	0.00118	CcSEcCtD
Fluorouracil—Body temperature increased—Capecitabine—colon cancer	2.78e-05	0.00118	CcSEcCtD
Fluorouracil—Convulsion—Methotrexate—colon cancer	2.78e-05	0.00118	CcSEcCtD
Fluorouracil—Chest pain—Methotrexate—colon cancer	2.73e-05	0.00116	CcSEcCtD
Fluorouracil—Myalgia—Methotrexate—colon cancer	2.73e-05	0.00116	CcSEcCtD
Fluorouracil—Discomfort—Methotrexate—colon cancer	2.69e-05	0.00114	CcSEcCtD
Fluorouracil—Confusional state—Methotrexate—colon cancer	2.64e-05	0.00112	CcSEcCtD
Fluorouracil—Anaphylactic shock—Methotrexate—colon cancer	2.61e-05	0.00111	CcSEcCtD
Fluorouracil—Infection—Methotrexate—colon cancer	2.6e-05	0.0011	CcSEcCtD
Fluorouracil—Hypersensitivity—Capecitabine—colon cancer	2.59e-05	0.0011	CcSEcCtD
Fluorouracil—Nervous system disorder—Methotrexate—colon cancer	2.56e-05	0.00109	CcSEcCtD
Fluorouracil—Thrombocytopenia—Methotrexate—colon cancer	2.56e-05	0.00109	CcSEcCtD
Fluorouracil—Anorexia—Methotrexate—colon cancer	2.49e-05	0.00106	CcSEcCtD
Fluorouracil—Pruritus—Capecitabine—colon cancer	2.48e-05	0.00105	CcSEcCtD
Fluorouracil—Hypotension—Methotrexate—colon cancer	2.44e-05	0.00104	CcSEcCtD
Fluorouracil—Diarrhoea—Capecitabine—colon cancer	2.4e-05	0.00102	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Methotrexate—colon cancer	2.38e-05	0.00101	CcSEcCtD
Fluorouracil—Insomnia—Methotrexate—colon cancer	2.36e-05	0.001	CcSEcCtD
Fluorouracil—Paraesthesia—Methotrexate—colon cancer	2.35e-05	0.000996	CcSEcCtD
Fluorouracil—Dyspnoea—Methotrexate—colon cancer	2.33e-05	0.000989	CcSEcCtD
Fluorouracil—Somnolence—Methotrexate—colon cancer	2.32e-05	0.000986	CcSEcCtD
Fluorouracil—Dizziness—Capecitabine—colon cancer	2.32e-05	0.000985	CcSEcCtD
Fluorouracil—Dyspepsia—Methotrexate—colon cancer	2.3e-05	0.000976	CcSEcCtD
Fluorouracil—Decreased appetite—Methotrexate—colon cancer	2.27e-05	0.000964	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Methotrexate—colon cancer	2.26e-05	0.000958	CcSEcCtD
Fluorouracil—Pain—Methotrexate—colon cancer	2.24e-05	0.000949	CcSEcCtD
Fluorouracil—Vomiting—Capecitabine—colon cancer	2.23e-05	0.000947	CcSEcCtD
Fluorouracil—Rash—Capecitabine—colon cancer	2.21e-05	0.00094	CcSEcCtD
Fluorouracil—Dermatitis—Capecitabine—colon cancer	2.21e-05	0.000939	CcSEcCtD
Fluorouracil—Headache—Capecitabine—colon cancer	2.2e-05	0.000934	CcSEcCtD
Fluorouracil—Feeling abnormal—Methotrexate—colon cancer	2.15e-05	0.000914	CcSEcCtD
Fluorouracil—Nausea—Capecitabine—colon cancer	2.09e-05	0.000885	CcSEcCtD
Fluorouracil—Urticaria—Methotrexate—colon cancer	2.08e-05	0.000881	CcSEcCtD
Fluorouracil—Body temperature increased—Methotrexate—colon cancer	2.07e-05	0.000877	CcSEcCtD
Fluorouracil—Hypersensitivity—Methotrexate—colon cancer	1.93e-05	0.000817	CcSEcCtD
Fluorouracil—Pruritus—Methotrexate—colon cancer	1.85e-05	0.000785	CcSEcCtD
Fluorouracil—Diarrhoea—Methotrexate—colon cancer	1.79e-05	0.000759	CcSEcCtD
Fluorouracil—Dizziness—Methotrexate—colon cancer	1.73e-05	0.000734	CcSEcCtD
Fluorouracil—Vomiting—Methotrexate—colon cancer	1.66e-05	0.000705	CcSEcCtD
Fluorouracil—Rash—Methotrexate—colon cancer	1.65e-05	0.000699	CcSEcCtD
Fluorouracil—Dermatitis—Methotrexate—colon cancer	1.65e-05	0.000699	CcSEcCtD
Fluorouracil—Headache—Methotrexate—colon cancer	1.64e-05	0.000695	CcSEcCtD
Fluorouracil—Nausea—Methotrexate—colon cancer	1.55e-05	0.000659	CcSEcCtD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	1.33e-05	0.000691	CbGpPWpGaD
Fluorouracil—ABCC5—Transmembrane transport of small molecules—ABCB1—colon cancer	1.3e-05	0.000677	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	1.29e-05	0.000672	CbGpPWpGaD
Fluorouracil—TYMS—Circadian rythm related genes—EP300—colon cancer	1.28e-05	0.000663	CbGpPWpGaD
Fluorouracil—UMPS—Metabolism—PTGS2—colon cancer	1.27e-05	0.000658	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	1.26e-05	0.000654	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—colon cancer	1.23e-05	0.000639	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—CA7—colon cancer	1.2e-05	0.000625	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—CA7—colon cancer	1.19e-05	0.000621	CbGpPWpGaD
Fluorouracil—ABCC3—NRF2 pathway—TGFB1—colon cancer	1.19e-05	0.000616	CbGpPWpGaD
Fluorouracil—UPP2—Metabolism—PTGS2—colon cancer	1.18e-05	0.000612	CbGpPWpGaD
Fluorouracil—UPP1—Metabolism—PTGS2—colon cancer	1.18e-05	0.000612	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—ODC1—colon cancer	1.17e-05	0.00061	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—CHST5—colon cancer	1.17e-05	0.00061	CbGpPWpGaD
Fluorouracil—ABCC4—Ectoderm Differentiation—MYC—colon cancer	1.17e-05	0.000608	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	1.16e-05	0.000602	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	1.16e-05	0.000601	CbGpPWpGaD
Fluorouracil—CYP1A2—Arachidonic acid metabolism—PTGS2—colon cancer	1.15e-05	0.000598	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	1.13e-05	0.000589	CbGpPWpGaD
Fluorouracil—SLC22A7—Transmembrane transport of small molecules—ABCB1—colon cancer	1.12e-05	0.000582	CbGpPWpGaD
Fluorouracil—ABCC4—NRF2 pathway—TGFB1—colon cancer	1.12e-05	0.00058	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—colon cancer	1.07e-05	0.000559	CbGpPWpGaD
Fluorouracil—ABCG2—HIF-1-alpha transcription factor network—AKT1—colon cancer	1.07e-05	0.000558	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	1.07e-05	0.000556	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—ODC1—colon cancer	1.07e-05	0.000554	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—CHST5—colon cancer	1.07e-05	0.000554	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—ABCB1—colon cancer	1.06e-05	0.000552	CbGpPWpGaD
Fluorouracil—UMPS—Metabolism—EP300—colon cancer	1.05e-05	0.000547	CbGpPWpGaD
Fluorouracil—ALB—Selenium Micronutrient Network—PTGS2—colon cancer	1.05e-05	0.000544	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—TYMS—colon cancer	1.04e-05	0.000542	CbGpPWpGaD
Fluorouracil—DPYD—Metabolism—PPARG—colon cancer	1.04e-05	0.000539	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—PPARG—colon cancer	1.04e-05	0.000539	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor—EP300—colon cancer	1.02e-05	0.000532	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—colon cancer	1.02e-05	0.000532	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor—SRC—colon cancer	9.95e-06	0.000517	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—colon cancer	9.95e-06	0.000517	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	9.83e-06	0.000511	CbGpPWpGaD
Fluorouracil—UPP1—Metabolism—EP300—colon cancer	9.79e-06	0.000509	CbGpPWpGaD
Fluorouracil—UPP2—Metabolism—EP300—colon cancer	9.79e-06	0.000509	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CA7—colon cancer	9.78e-06	0.000508	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—colon cancer	9.69e-06	0.000504	CbGpPWpGaD
Fluorouracil—ABCC3—Transmembrane transport of small molecules—ABCB1—colon cancer	9.6e-06	0.000499	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—colon cancer	9.57e-06	0.000497	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	9.51e-06	0.000495	CbGpPWpGaD
Fluorouracil—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—colon cancer	9.16e-06	0.000476	CbGpPWpGaD
Fluorouracil—TYMS—Circadian rythm related genes—TP53—colon cancer	9.13e-06	0.000475	CbGpPWpGaD
Fluorouracil—ABCC4—Transmembrane transport of small molecules—ABCB1—colon cancer	9.03e-06	0.000469	CbGpPWpGaD
Fluorouracil—ABCC4—Platelet activation, signaling and aggregation—SRC—colon cancer	8.95e-06	0.000465	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor—MYC—colon cancer	8.91e-06	0.000463	CbGpPWpGaD
Fluorouracil—ALB—Platelet degranulation—VEGFA—colon cancer	8.9e-06	0.000462	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—colon cancer	8.89e-06	0.000462	CbGpPWpGaD
Fluorouracil—ABCC4—Platelet activation, signaling and aggregation—VEGFA—colon cancer	8.72e-06	0.000453	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—colon cancer	8.72e-06	0.000453	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—colon cancer	8.72e-06	0.000453	CbGpPWpGaD
Fluorouracil—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—colon cancer	8.47e-06	0.00044	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CA7—colon cancer	8.36e-06	0.000434	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—colon cancer	8.24e-06	0.000428	CbGpPWpGaD
Fluorouracil—ALB—Platelet degranulation—TGFB1—colon cancer	8.16e-06	0.000424	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—PTGS2—colon cancer	8.16e-06	0.000424	CbGpPWpGaD
Fluorouracil—DPYD—Metabolism—PTGS2—colon cancer	8.16e-06	0.000424	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	8.03e-06	0.000418	CbGpPWpGaD
Fluorouracil—ABCC4—Platelet activation, signaling and aggregation—TGFB1—colon cancer	8e-06	0.000416	CbGpPWpGaD
Fluorouracil—ALB—Folate Metabolism—TP53—colon cancer	7.84e-06	0.000407	CbGpPWpGaD
Fluorouracil—UMPS—Metabolism—PIK3CA—colon cancer	7.79e-06	0.000405	CbGpPWpGaD
Fluorouracil—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—colon cancer	7.78e-06	0.000404	CbGpPWpGaD
Fluorouracil—CYP2A6—NRF2 pathway—TGFB1—colon cancer	7.43e-06	0.000386	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—PPARG—colon cancer	7.39e-06	0.000384	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—ODC1—colon cancer	7.28e-06	0.000378	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—CHST5—colon cancer	7.28e-06	0.000378	CbGpPWpGaD
Fluorouracil—UPP2—Metabolism—PIK3CA—colon cancer	7.24e-06	0.000376	CbGpPWpGaD
Fluorouracil—UPP1—Metabolism—PIK3CA—colon cancer	7.24e-06	0.000376	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—CHST5—colon cancer	7.24e-06	0.000376	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—ODC1—colon cancer	7.24e-06	0.000376	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism of lipids and lipoproteins—PPARG—colon cancer	7.02e-06	0.000365	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—ABCB1—colon cancer	7.01e-06	0.000364	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—colon cancer	7e-06	0.000364	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle, Mitotic—CCND1—colon cancer	6.99e-06	0.000363	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—TYMS—colon cancer	6.88e-06	0.000358	CbGpPWpGaD
Fluorouracil—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—colon cancer	6.81e-06	0.000354	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—EP300—colon cancer	6.78e-06	0.000353	CbGpPWpGaD
Fluorouracil—DPYD—Metabolism—EP300—colon cancer	6.78e-06	0.000353	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle, Mitotic—CDKN1A—colon cancer	6.76e-06	0.000352	CbGpPWpGaD
Fluorouracil—ABCG2—Transmembrane transport of small molecules—ABCB1—colon cancer	6.62e-06	0.000344	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—FGFR3—colon cancer	6.57e-06	0.000341	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle, Mitotic—EP300—colon cancer	6.44e-06	0.000335	CbGpPWpGaD
Fluorouracil—UMPS—Metabolism—AKT1—colon cancer	6.36e-06	0.000331	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—CCND1—colon cancer	6.25e-06	0.000325	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—ABCB1—colon cancer	6.1e-06	0.000317	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—CDKN1A—colon cancer	6.05e-06	0.000314	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—APC—colon cancer	6.03e-06	0.000313	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—TYMS—colon cancer	5.99e-06	0.000311	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CHST5—colon cancer	5.92e-06	0.000308	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ODC1—colon cancer	5.92e-06	0.000308	CbGpPWpGaD
Fluorouracil—UPP2—Metabolism—AKT1—colon cancer	5.91e-06	0.000307	CbGpPWpGaD
Fluorouracil—UPP1—Metabolism—AKT1—colon cancer	5.91e-06	0.000307	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—PTGS2—colon cancer	5.81e-06	0.000302	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—EP300—colon cancer	5.75e-06	0.000299	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—FGFR3—colon cancer	5.72e-06	0.000297	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—BRAF—colon cancer	5.67e-06	0.000295	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle, Mitotic—MYC—colon cancer	5.61e-06	0.000292	CbGpPWpGaD
Fluorouracil—ABCC4—Platelet activation, signaling and aggregation—AKT1—colon cancer	5.56e-06	0.000289	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	5.53e-06	0.000287	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—ABCB1—colon cancer	5.43e-06	0.000282	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—APC—colon cancer	5.25e-06	0.000273	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ODC1—colon cancer	5.06e-06	0.000263	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CHST5—colon cancer	5.06e-06	0.000263	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—PIK3CA—colon cancer	5.02e-06	0.000261	CbGpPWpGaD
Fluorouracil—DPYD—Metabolism—PIK3CA—colon cancer	5.02e-06	0.000261	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—MYC—colon cancer	5.01e-06	0.000261	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—BRAF—colon cancer	4.93e-06	0.000256	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—PPARG—colon cancer	4.87e-06	0.000253	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—EP300—colon cancer	4.83e-06	0.000251	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—EP300—colon cancer	4.75e-06	0.000247	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—SRC—colon cancer	4.61e-06	0.00024	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism of lipids and lipoproteins—EP300—colon cancer	4.6e-06	0.000239	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—PTGS2—colon cancer	4.58e-06	0.000238	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—ABCB1—colon cancer	4.5e-06	0.000234	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—VEGFA—colon cancer	4.49e-06	0.000234	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—NRAS—colon cancer	4.44e-06	0.000231	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—TYMS—colon cancer	4.42e-06	0.00023	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—PPARG—colon cancer	4.24e-06	0.000221	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—TGFB1—colon cancer	4.13e-06	0.000214	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—TP53—colon cancer	4.12e-06	0.000214	CbGpPWpGaD
Fluorouracil—DPYD—Metabolism—AKT1—colon cancer	4.1e-06	0.000213	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—AKT1—colon cancer	4.1e-06	0.000213	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—CTNNB1—colon cancer	4.1e-06	0.000213	CbGpPWpGaD
Fluorouracil—ALB—Transmembrane transport of small molecules—ABCB1—colon cancer	4.08e-06	0.000212	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—SRC—colon cancer	4.05e-06	0.000211	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—CDKN1A—colon cancer	4e-06	0.000208	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—PTGS2—colon cancer	3.99e-06	0.000207	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—VEGFA—colon cancer	3.95e-06	0.000205	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—PTGS2—colon cancer	3.83e-06	0.000199	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—KRAS—colon cancer	3.82e-06	0.000199	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—EP300—colon cancer	3.81e-06	0.000198	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—PPARG—colon cancer	3.78e-06	0.000196	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—SRC—colon cancer	3.7e-06	0.000192	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—TGFB1—colon cancer	3.62e-06	0.000188	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—PIK3CA—colon cancer	3.58e-06	0.000186	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—CTNNB1—colon cancer	3.57e-06	0.000185	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—NRAS—colon cancer	3.56e-06	0.000185	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—PIK3CA—colon cancer	3.51e-06	0.000182	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—CDKN1A—colon cancer	3.48e-06	0.000181	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	3.4e-06	0.000177	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—TP53—colon cancer	3.4e-06	0.000177	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—PTGS2—colon cancer	3.34e-06	0.000173	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—MYC—colon cancer	3.32e-06	0.000172	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—EP300—colon cancer	3.31e-06	0.000172	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—TGFB1—colon cancer	3.31e-06	0.000172	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—HRAS—colon cancer	3.25e-06	0.000169	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—EGFR—colon cancer	3.25e-06	0.000169	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—SRC—colon cancer	3.22e-06	0.000168	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—EP300—colon cancer	3.19e-06	0.000166	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PPARG—colon cancer	3.13e-06	0.000163	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—NRAS—colon cancer	3.1e-06	0.000161	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—ABCB1—colon cancer	3.1e-06	0.000161	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—PIK3CA—colon cancer	3.08e-06	0.00016	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—KRAS—colon cancer	3.07e-06	0.000159	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—TYMS—colon cancer	3.04e-06	0.000158	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—colon cancer	3.01e-06	0.000156	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—PPARG—colon cancer	2.99e-06	0.000155	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—PTGS2—colon cancer	2.97e-06	0.000155	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—AKT1—colon cancer	2.92e-06	0.000152	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—MYC—colon cancer	2.89e-06	0.00015	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—TGFB1—colon cancer	2.88e-06	0.00015	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—AKT1—colon cancer	2.87e-06	0.000149	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—EGFR—colon cancer	2.83e-06	0.000147	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—PIK3CA—colon cancer	2.82e-06	0.000146	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—ABCB1—colon cancer	2.82e-06	0.000146	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—EP300—colon cancer	2.78e-06	0.000144	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—TYMS—colon cancer	2.77e-06	0.000144	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—KRAS—colon cancer	2.67e-06	0.000139	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—HRAS—colon cancer	2.61e-06	0.000135	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—AKT1—colon cancer	2.52e-06	0.000131	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—EP300—colon cancer	2.47e-06	0.000129	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PTGS2—colon cancer	2.46e-06	0.000128	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—PIK3CA—colon cancer	2.45e-06	0.000127	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—colon cancer	2.45e-06	0.000127	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	2.36e-06	0.000123	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—PIK3CA—colon cancer	2.36e-06	0.000123	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	2.35e-06	0.000122	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—AKT1—colon cancer	2.3e-06	0.00012	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—HRAS—colon cancer	2.27e-06	0.000118	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PPARG—colon cancer	2.16e-06	0.000112	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—EP300—colon cancer	2.15e-06	0.000112	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—colon cancer	2.09e-06	0.000109	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—SRC—colon cancer	2.09e-06	0.000109	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—PIK3CA—colon cancer	2.05e-06	0.000107	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—EP300—colon cancer	2.05e-06	0.000106	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—VEGFA—colon cancer	2.03e-06	0.000106	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—NRAS—colon cancer	2.01e-06	0.000104	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—AKT1—colon cancer	2e-06	0.000104	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.97e-06	0.000102	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PPARG—colon cancer	1.96e-06	0.000102	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.95e-06	0.000102	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—AKT1—colon cancer	1.93e-06	0.0001	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.92e-06	0.0001	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—ABCB1—colon cancer	1.92e-06	0.0001	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—ABCB1—colon cancer	1.91e-06	9.94e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—TYMS—colon cancer	1.89e-06	9.82e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—TYMS—colon cancer	1.88e-06	9.76e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—TGFB1—colon cancer	1.87e-06	9.7e-05	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—PIK3CA—colon cancer	1.83e-06	9.51e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—KRAS—colon cancer	1.73e-06	8.99e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PTGS2—colon cancer	1.7e-06	8.82e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—AKT1—colon cancer	1.68e-06	8.72e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.64e-06	8.55e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.6e-06	8.32e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—PIK3CA—colon cancer	1.59e-06	8.26e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ABCB1—colon cancer	1.57e-06	8.14e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PTGS2—colon cancer	1.54e-06	8.01e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—TYMS—colon cancer	1.54e-06	7.99e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—TP53—colon cancer	1.54e-06	7.99e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PIK3CA—colon cancer	1.51e-06	7.87e-05	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—AKT1—colon cancer	1.49e-06	7.77e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—HRAS—colon cancer	1.47e-06	7.64e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.45e-06	7.56e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.45e-06	7.52e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—EP300—colon cancer	1.41e-06	7.33e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.37e-06	7.11e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PPARG—colon cancer	1.34e-06	6.96e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ABCB1—colon cancer	1.34e-06	6.95e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PPARG—colon cancer	1.33e-06	6.92e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—TYMS—colon cancer	1.31e-06	6.83e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—AKT1—colon cancer	1.3e-06	6.75e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—EP300—colon cancer	1.28e-06	6.66e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—AKT1—colon cancer	1.24e-06	6.43e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.18e-06	6.15e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PPARG—colon cancer	1.09e-06	5.66e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PTGS2—colon cancer	1.05e-06	5.47e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PTGS2—colon cancer	1.05e-06	5.44e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PIK3CA—colon cancer	1.04e-06	5.43e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.01e-06	5.26e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PIK3CA—colon cancer	9.48e-07	4.93e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PPARG—colon cancer	9.31e-07	4.84e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—EP300—colon cancer	8.76e-07	4.55e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—EP300—colon cancer	8.71e-07	4.53e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PTGS2—colon cancer	8.57e-07	4.45e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—AKT1—colon cancer	8.53e-07	4.43e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—AKT1—colon cancer	7.75e-07	4.03e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PTGS2—colon cancer	7.32e-07	3.81e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—EP300—colon cancer	7.13e-07	3.7e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PIK3CA—colon cancer	6.48e-07	3.37e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PIK3CA—colon cancer	6.44e-07	3.35e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—EP300—colon cancer	6.09e-07	3.17e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—AKT1—colon cancer	5.29e-07	2.75e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PIK3CA—colon cancer	5.27e-07	2.74e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—AKT1—colon cancer	5.26e-07	2.73e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PIK3CA—colon cancer	4.5e-07	2.34e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—AKT1—colon cancer	4.31e-07	2.24e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—AKT1—colon cancer	3.68e-07	1.91e-05	CbGpPWpGaD
